What does everyone think about the oncology spinoff? I understand the desire to unlock value but doesn’t that leave legacy Alkermes with nothing of value?
What does everyone think about the oncology spinoff? I understand the desire to unlock value but doesn’t that leave legacy Alkermes with nothing of value?
Aristada and Vivitrol have run their course. Lybalvi is not living up to expectations.
Pops is like a cat chasing a laser pointer.
Addiction and psychiatry are short lived
Aristada and Vivitrol have run their course. Lybalvi is not living up to expectations.
Pops is like a cat chasing a laser pointer.
Addiction and psychiatry are short lived
Based on his performance during the TH Meeting, you would think he has singlehandedly guided the BD process here at ALKS. Based on what I'm seeing, I wouldn't want to be associated with this Neuropsyche trainwreck.